BRCA2 and cancer: The identification of a pathogenic variant in BRCA1, BRCA2, or another gene associated with breast cancer, is also associated with potential benefits for the woman’s family, as it may influence relatives to opt for genetic counseling and testing to identify healthy carriers at high risk, and thereby be able to prevent cancer and cancer-related deaths through increased surveillance and prophylactic surgery [10, 11].